Moratorium on stem cell treatment in PH a must for now

THIS IS in reference to the latest Department of Health warning on the use of stem cells from aborted fetuses (“DOH warns against use of stem cells from aborted babies,” Inquirer, 11/11/12). It is my humble opinion as a Filipino medical practitioner that the most logical and effective way for the DOH to fulfill its function of protecting and safeguarding the health of Filipino patients from dubious stem cell treatment is to immediately impose a moratorium on stem cell therapy in the country.

In developed countries, novel stem cell treatment can only be tried on patients under a strict clinical trial environment. For example, if one tries to treat cancer or diabetes mellitus with stem cells using a protocol not approved by the US Food and Drug Administration (US FDA), one has to submit first to the US FDA voluminous scientific documents supporting or justifying the trial, based on pre-clinical studies. The trial is  undertaken only after approval by the US FDA and institutional review boards, and usually the patients are treated for free or at a minimal patient expense. The treatment protocol is also open for review and the treatment results, both positive and negative, are meticulously monitored, reported and preferably published in a peer-reviewed medical journal.

In the Philippines, some medical centers are currently giving stem cell treatment for a variety of conditions that had not been approved by the US FDA. The DOH mentioned that they will just be regulating and monitoring these centers (or the quality of their stem cells), but it is not saying anything yet about stopping the practice of delivering unproven stem cell treatments. I respectfully believe that this is the wrong approach and that it is paramount that the DOH should prioritize the safety and interests of Filipino patients rather than the financial interests of hospitals and doctors who have already invested in the technology. Of course, those few stem cell treatments that are approved by the US FDA (some blood cancers, prostatic cancer, etc.) should be the only ones allowed to continue for now until the DOH finalizes its regulatory guidelines.

—JOSE A. AGUILAR, M.D., consultant,

Philippine Children’s Medical Center,


Follow Us

Follow us on Facebook Follow on Twitter Follow on Twitter

Other Stories:

No related posts found!

Recent Stories:

Complete stories on our Digital Edition newsstand for tablets, netbooks and mobile phones; 14-issue free trial. About to step out? Get breaking alerts on your mobile.phone. Text ON INQ BREAKING to 4467, for Globe, Smart and Sun subscribers in the Philippines.

Short URL: http://opinion.inquirer.net/?p=41355

Tags: letters , stem cell treatment

Copyright © 2014, .
To subscribe to the Philippine Daily Inquirer newspaper in the Philippines, call +63 2 896-6000 for Metro Manila and Metro Cebu or email your subscription request here.
Factual errors? Contact the Philippine Daily Inquirer's day desk. Believe this article violates journalistic ethics? Contact the Inquirer's Reader's Advocate. Or write The Readers' Advocate:
c/o Philippine Daily Inquirer Chino Roces Avenue corner Yague and Mascardo Streets, Makati City, Metro Manila, Philippines Or fax nos. +63 2 8974793 to 94


  • Former solon, 2 others sanctioned for unfair labor practice
  • Let us pray for the nation, healing priest asks leaders
  • AFTA to kill PH agri industry in 2015, says neophyte senator
  • Blame game on as Edsa repairs miss deadline
  • Baptist church ransacked; even spoons, forks stolen
  • Sports

  • Wawrinka beats Federer to win Monte Carlo Masters
  • Rain or Shine grabs No.4, sends Ginebra to 8th
  • Red-hot Alaska rips injury-depleted San Mig Coffee
  • Pacquiao courtesy call to Aquino set for Monday
  • Nick Calathes suspension a reminder of supplement risk
  • Lifestyle

  • Transitions and resurrection in the performing arts
  • ‘Archaeology tour’ of Cebu’s heritage of faith
  • Historic Fort Bonifacio tunnel converted into a septic tank
  • ‘Imports’ from London, and play of the year
  • Korean animation comes of age
  • Entertainment

  • Easter musings
  • Solenn in shorts
  • Unmerry mix of attention-calling moves on ‘Mini-Me’ TV tilts
  • Persistence pays off for The 1975
  • Special section in LA fest for Filipino films
  • Business

  • BDO seen keen on bidding for Cocobank
  • Bataan freeport investment pledges up 1,302%
  • Golden Week
  • Bourse to woo Cebu stock mart investors
  • Supper power
  • Technology

  • Nasa’s moon-orbiting robot crashes down
  • Netizens pay respects to Gabriel Garcia Marquez
  • Nokia recalls 30,000 chargers for Lumia 2520 tablet
  • Facebook rolls out ‘nearby friends’ feature
  • Netizens seethe over Aquino’s ‘sacrifice’ message
  • Opinion

  • Gigi’s home
  • Palace stonewalls on MRT inquiry
  • Couple of things too
  • There is plenty of water behind Wawa Dam
  • Triduum thoughts of a young boy
  • Global Nation

  • Japan presents $57-B ‘dream plan’ to solve Metro congestion
  • Tim Tebow’s charity hospital in Davao seen to open in 7 months
  • OFW died of Mers-CoV in Saudi Arabia, says family
  • Aquino, Obama to tackle US pivot to Asia during state visit
  • Asia seeks Obama’s assurance in territorial spats
  • Marketplace